Dimensional Fund Advisors LP Has $82.35 Million Stock Position in AdaptHealth Corp. $AHCO

Dimensional Fund Advisors LP lifted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 8.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,920,973 shares of the company’s stock after acquiring an additional 518,274 shares during the period. Dimensional Fund Advisors LP owned approximately 0.05% of AdaptHealth worth $82,353,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in AHCO. Assetmark Inc. grew its holdings in AdaptHealth by 54.8% during the first quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after buying an additional 2,460 shares in the last quarter. Bessemer Group Inc. lifted its stake in AdaptHealth by 47.8% during the 1st quarter. Bessemer Group Inc. now owns 482,937 shares of the company’s stock valued at $5,746,000 after acquiring an additional 156,095 shares in the last quarter. Bastion Asset Management Inc. boosted its holdings in AdaptHealth by 4.9% during the 1st quarter. Bastion Asset Management Inc. now owns 555,764 shares of the company’s stock worth $6,157,000 after acquiring an additional 25,751 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in AdaptHealth during the 1st quarter worth $120,000. Finally, Principal Financial Group Inc. boosted its holdings in AdaptHealth by 25.1% during the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after acquiring an additional 558,357 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Insiders Place Their Bets

In related news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $10.06, for a total transaction of $113,426.50. Following the completion of the sale, the insider owned 136,538 shares in the company, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.95% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and upped their price objective for the stock from $11.00 to $13.00 in a research report on Tuesday, July 21st. UBS Group decreased their price objective on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Finally, Canaccord Genuity Group lifted their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Seven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $14.14.

AdaptHealth Trading Down 1.0%

NASDAQ AHCO opened at $10.68 on Friday. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -17.23, a PEG ratio of 0.55 and a beta of 1.45. AdaptHealth Corp. has a one year low of $8.51 and a one year high of $13.43. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.92 and a quick ratio of 0.71. The business’s fifty day moving average is $10.27 and its 200-day moving average is $10.67.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.